Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion type Assertion NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_head.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion description "[Together, these observations suggest that activation of CRLF2 expression, mutation of JAK kinases, and alterations of IKZF1 cooperate to promote B-cell leukemogenesis and identify these pathways as important therapeutic targets in this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion evidence source_evidence_literature NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion SIO_000772 20139093 NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion wasDerivedFrom befree-20140225 NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion wasGeneratedBy ECO_0000203 NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.